NxThera

Medical Alley Powering the Evolution of Healthcare with More Than $2.8 Billion Invested and $2 Billion in Exits

Medical Alley companies have raised more than $2.8 billion over the past 5 years, furthering the region’s reputation as the global epicenter of health innovation and care. For the second year in a row, Medical Alley’s diverse healthcare ecosystem raised more than $700 million across the sectors of medical device, digital health, biotechnology and new […]

In The Know: December 6, 2018

Nearly 150 groups join AdvaMed’s anti medtech tax letter Inspire Medical offers another 1.5 million shares following April IPO   POPS! Diabetes Care Announces FDA Clearance of Their POPS!® one System   NxThera spinout NxPhase lands $10m for vapor ablation tech   Mayo Clinic Startup Phenomix Sciences Initiates $1M Seed Funding Round   IPM Earns […]

Medical Alley Companies Raise $234 Million in First Half of 2018

Medical Alley companies had a strong start to 2018, buoyed by new investments in biotech. 45 companies raised $234 million in the first half of the year. In addition to positive investment flow, exits continued at a strong pace with multiple acquisitions and one initial public offering (IPO). These exits will recycle capital into the […]

Payers, Providers, and Health Technology Experts Join Forces at DeviceTalks 2018

While DeviceTalks 2018 was held in the same location as the 2017 iteration of the conference, it was clear that its reputation had grown and attendance had grown with it. Spread across three floors of the Intercontinental Riverfront in downtown St. Paul, DeviceTalks brought together senior staff from across the United States for two days […]

Record Q1 Investment Showcases Shift to Consumer-Focused Health

Q1 record with 26 Medical Alley companies raising $112 million in capital and a pair of companies acquired for $1.6 billion. Investors are backing Medical Alley companies leading a shift to a consumer- and patient-centric healthcare system. Building on a record 2017, Medical Alley’s leadership continued in a record Q1 that saw $112 million raised […]

NxThera Acquired by Boston Scientific, Will Form New Cancer Therapy Company

On March 21st, Boston Scientific announced its intent to acquire Medical Alley-based NxThera, a medical device company developing the Rezūm system, a revolutionary, safe, and cost-effective minimally invasive treatment option for men suffering from benign prostatic hyperplasia (BPH). “We are excited to announce this agreement with Boston Scientific,” said Bob Paulson, president and chief executive […]

January 3, 2018: In the Know

BIO-TECHNE ACQUIRES ATLANTA BIOLOGICALS INC. ImpediMed Launches FDA-Cleared SOZO™ System ANI Pharmaceuticals Acquires Four NDAs from AstraZeneca for $46.5 Million Initial Publication from Prospective, Multi-center Study on SImmetry Sacroiliac (SI) Joint Fusion Shows Significant Reduction in Low Back Pain and Opioid Use at 6 Months Horizon Technology Finance Provides $12 Million Venture Loan to Conventus […]

August 31, 2017: In the Know

Smiths Medical Receives FDA 510(k) Clearance on Wireless Ambulatory Infusion Pump Abeona Therapeutics Receives FDA Breakthrough Therapy Designation for EB-101 Autologous Cell Therapy in Epidermolysis Bullosa Resonetics acquires Aduro Laser Abbott Gets Approval to Sell New Pump to Treat Heart Failure NxThera Announces Positive Results of Post-Market Study of Its Minimally Invasive Rezūm® System Startup […]

April 6, 2017: In the Know

SpineThera Receives $2 Million Grant from U.S. Army MetaModix Raises $1.2M Cardiovascular Systems Secures $40 Million Line of Credit from Silicon Valley Bank Prime Therapeutics Wins $15B Contract Covering Federal Employees UnitedHealth’s Optum Steps Up its Venture Deal-Making NxThera Announces Humana and Aetna Coverage of the Rezūm System to Treat BPH HLT Announces First Patient […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER